GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for ...
Inspira entered into a non-binding term sheet, outlining the principal terms of a proposed two-part transaction that would include the acquisition of an advanced liquid biopsy diagnostics business, ...
A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...
RA'ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, ...
Medical Device Network on MSN
Artera’s prostate biopsy and breast cancer assays receive CE mark
The ArteraAI prostate biopsy assay predicts the risk of prostate cancer progression.
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence. The new technology has the potential to improve cancer ...
LAFAYETTE, La. (KLFY) — Our Lady of Lourdes is now offering patients the latest in lung cancer treatment using AI. The new artificial intelligence-based software and robot-assisted biopsy technology ...
CAMPBELL, Calif.--(BUSINESS WIRE)--Body Vision Medical, a leader in AI-driven, intraoperative image guidance, today announced that its LungVision® system has been selected as the winner of the “Best ...
Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early detection plays a crucial role in reducing cancer-related morbidity and ...
An artificial intelligence-powered method for detecting tumor DNA in blood has shown unprecedented sensitivity in predicting cancer recurrence, in a study led by researchers at Weill Cornell Medicine, ...
Novel research in The Journal of Molecular Diagnostics details the new method, Bridge Capture, which advances cancer diagnostics and monitoring via liquid biopsies. The cell-free DNA isolated from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results